PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19554262-0	2010	Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib.	Nelfinavir	0-10	mitogen-activated protein kinase 3	Homo sapiens	46-52	
19554262-6	2010	The combination of nelfinavir with sorafenib, a clinically applied inhibitor of the RAS/RAF/ERK1/2 pathway, inhibited nelfinavir-induced ERK1/2 activation and mcl-1 protein upregulation.	Nelfinavir	19-29	mitogen-activated protein kinase 3	Homo sapiens	92-98	
19554262-6	2010	The combination of nelfinavir with sorafenib, a clinically applied inhibitor of the RAS/RAF/ERK1/2 pathway, inhibited nelfinavir-induced ERK1/2 activation and mcl-1 protein upregulation.	Nelfinavir	19-29	mitogen-activated protein kinase 3	Homo sapiens	137-143	
22271897-10	2012	Cell death triggered by nelfinavir treatment correlated with decreased phosphorylation of AKT, STAT3 and ERK1/2.	Nelfinavir	24-34	mitogen-activated protein kinase 3	Homo sapiens	105-111	
19554262-6	2010	The combination of nelfinavir with sorafenib, a clinically applied inhibitor of the RAS/RAF/ERK1/2 pathway, inhibited nelfinavir-induced ERK1/2 activation and mcl-1 protein upregulation.	Nelfinavir	118-128	mitogen-activated protein kinase 3	Homo sapiens	92-98	
19554262-6	2010	The combination of nelfinavir with sorafenib, a clinically applied inhibitor of the RAS/RAF/ERK1/2 pathway, inhibited nelfinavir-induced ERK1/2 activation and mcl-1 protein upregulation.	Nelfinavir	118-128	mitogen-activated protein kinase 3	Homo sapiens	137-143